روفلوميلاست
| Kind | API |
|---|---|
| Class | Respiratory anti-inflammatory — selective PDE4 inhibitor |
| Synonyms | B9302-107, APTA-2217, Daliresp, Daxas |
| Common uses / forms | Oral tablets 250 / 500 µg (severe COPD with bronchitis); topical cream in dermatology |
| Properties | Potent low-dose small molecule; poorly water soluble (BCS Class II/IV behaviour) — dissolution particle-size sensitive; active N-oxide metabolite; low-dose content uniformity critical |
| Sourcing origins | India, China, EU |
| Dominant inbound route | Hormuz |
| Indicative price band | $$$$ (> $1000 / kg) |
| Indicative lead time | medium (50–80 days) |
| Notes | Qualify against innovator/CEP specs where public monograph coverage is thin; genotoxic-impurity control and low-dose blend uniformity are key; post-patent Indian generics available |
Open the interactive Data Bank (363 substances) · the full table · Supply Resilience Studio
Share: LinkedIn · X · WhatsApp · Telegram · Email
Cite as: AUPAM Experts' Office, Roflumilast — sourcing profile (API) — AUPAM Data Bank, retrieved 2026-08-31, https://aupameo.org/datasets/databank/a-roflumilast.html